Cline Scientific
Shares subscribed by board and management in Cline's ongoing rights issue
Acting CEO Hanne Evenbratt and board member Patrik Sundh subscribe for Series A shares in Cline's ongoing rights issue. Hanne subscribes to 312,500 Series A shares and Patrik 650,000 Series A shares, for a total of SEK 231,000.
These subscriptions of shares are in addition to the previously announced board members' subscription of Series B shares, details can be found in Cline's memorandum. Through these subscriptions, the board and management show their continued trust and foundational faith in Cline's future prospects.
The last day for subscription is July 12, 2023.
For more information, please contact:
Hanne Evenbratt, Interim CEO
Email: hanne.evenbratt@clinescientific.com
Phone: +46 704 88 79 23
| Datum | 2023-07-10, kl 11:26 |
| Källa | Cision |
Kopiera toppinvesterare! Med eToros innovativa CopyTrader™, kan du automatiskt kopiera andra investerares beslut. Hitta investerare som du tror på och kopiera deras investeringar i realtid. Inga extra avgifter tas ut för att använda CopyTrader-funktionen.
Copy Trading innebär inte investeringsråd. Värdet på dina investeringar kan gå upp eller ned. Ditt kapital löper risk.